Adverse drug reactions of itolizumab in COVID-19 patient: A case report,Ziauddin Mohammed1, Kandi Suryachandra2, Manoj P Dandekar2: Indian Journal of Pharmacology

Home

LETTER TO THE EDITOR	[View FULLTEXT] [Download PDF]

Year : 2022 \| Volume : 54 \| Issue : 5 \| Page : 377--378

Adverse drug reactions of itolizumab in COVID-19 patient: A case report

Ziauddin Mohammed¹, Kandi Suryachandra², Manoj P Dandekar²
¹ Department of Clinical Pharmacology, Apollo Hospitals, Jubilee Hills, Hyderabad, Telangana, India
² Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India

Correspondence Address:
Manoj P Dandekar
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana
India

How to cite this article:
Mohammed Z, Suryachandra K, Dandekar MP. Adverse drug reactions of itolizumab in COVID-19 patient: A case report.Indian J Pharmacol 2022;54:377-378

How to cite this URL:
Mohammed Z, Suryachandra K, Dandekar MP. Adverse drug reactions of itolizumab in COVID-19 patient: A case report. Indian J Pharmacol [serial online] 2022 [cited 2023 Jun 6 ];54:377-378
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2022;volume=54;issue=5;spage=377;epage=378;aulast=Mohammed;type=0